Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The CD4 molecule is a glycoprotein expressed on the surface of helper T (T_h) cells, monocytes, macrophages, and dendritic cells. It acts as a co-receptor for the T cell receptor (TCR) during antigen recognition by binding to MHC class II molecules on antigen-presenting cells. CD4 T-helper cells play a central role in orchestrating the adaptive immune response by helping activate B cells, cytotoxic T cells, and macrophages via cytokine secretion and cell-cell interactions. Stimulation of CD4 T-helper cells involves TCR engagement with antigen-MHC II complexes, co-receptor CD4 binding, co-stimulatory signals (e.g., CD28-CD80/86 interactions), and the integration of cytokine-driven differentiation pathways. This coordinated activation determines immune polarization and is critical for effective immunity, but dysregulation can contribute to infection susceptibility, autoimmunity, and immunopathology.
Modulation or blockade of CD4-mediated T cell activation, inhibition of HIV entry via gp120-CD4 interaction, immune suppression/modulation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD4 molecule (CD4).